{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T17:03:30Z","timestamp":1768755810983,"version":"3.49.0"},"reference-count":23,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Hypopigmented mycosis fungoides is a rare variant of mycosis fungoides often seen in younger patients and individuals with darker skin tones and is characterized by hypopigmented patches or plaques. The lesions are usually asymptomatic and respond well to topical treat-ment or phototherapy. This article presents a case of an adult Caucasian male with a rare variant of CD8-negativeh hypopigmented mycosis fungoides, with a rapid progression to erythrodermic lesions, failure of standard treatment, and a good response to mogamulizumab.<\/jats:p>","DOI":"10.2340\/actadv.v105.43932","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:57:51Z","timestamp":1766066271000},"page":"adv43932","source":"Crossref","is-referenced-by-count":1,"title":["Rapidly Progressing CD8-negative Hypopigmented Mycosis Fungoides in Adult Caucasian Male with Good Response to Mogamulizumab"],"prefix":"10.2340","volume":"105","author":[{"given":"Agnieszka","family":"Kimak-Pielas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taduesz","family":"Robak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"\u017bebrowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Robak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"136641","doi-asserted-by":"crossref","unstructured":"Furlan FC, Sanches JA. Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology. An Bras Dermatol 2013; 88: 954.","DOI":"10.1590\/abd1806-4841.20132336"},{"key":"136642","doi-asserted-by":"crossref","unstructured":"Qari MS, Li N, Demierre M-F. Hypopigmented mycosis fungoides: case reports and literature review. J Cutan Med Surg 2000; 4: 142\u2013148.","DOI":"10.1177\/120347540000400306"},{"key":"136643","doi-asserted-by":"crossref","unstructured":"Djawad K. Hypopigmented mycosis fungoides mimicking leprosy successfully treated with oral and topical corticosteroids: a new great imitator? Acta Dermatovenerol Alp Pannonica Adriat 2021; 30: 83\u201385.","DOI":"10.15570\/actaapa.2021.20"},{"key":"136644","doi-asserted-by":"crossref","unstructured":"Ardig\u00f3 M, Borroni G, Muscardin L, Kerl H, Cerroni L. Hypopigmented mycosis fungoides in Caucasian patients: a clinicopathologic study of 7 cases. J Am Acad Dermatol 2003; 49: 264\u2013270.","DOI":"10.1067\/S0190-9622(03)00907-1"},{"key":"136645","unstructured":"Rodney IJ, Kindred C, Angra K, Qutub ON, Villanueva AR, Halder RM. Hypopigmented mycosis fungoides: a retrospective"},{"key":"136646","doi-asserted-by":"crossref","unstructured":"clinicohistopathologic study. J Eur Acad Dermatol Venereol 2017; 31: 808\u2013814.","DOI":"10.1111\/jdv.13843"},{"key":"136647","doi-asserted-by":"crossref","unstructured":"Kim EJ, Hess S, Richardson SK, Newton S, Showe LC, Benoit BM, et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest 2005; 115: 798\u2013812.","DOI":"10.1172\/JCI24826"},{"key":"136648","doi-asserted-by":"crossref","unstructured":"Shi HZ, Jiang YQ, Xu XL, Zhang W, Song H, Wang XP, et al. Hypopigmented mycosis fungoides: a clinicopathological review of 32 patients. Clin Cosmet Investig Dermatol 2022; 15: 1259\u20131264.","DOI":"10.2147\/CCID.S370741"},{"key":"136649","unstructured":"Stone ML, Styles AR, Cockerell CJ, Pandya AG. Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature. Cutis 2001; 67: 133\u2013138."},{"key":"136650","doi-asserted-by":"crossref","unstructured":"Singh ZN, Tretiakova MS, Shea CR, Petronic-Rosic VM. Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo. Mod Pathol 2006; 19: 1255\u20131260.","DOI":"10.1038\/modpathol.3800644"},{"key":"136651","doi-asserted-by":"crossref","unstructured":"Kitamura R, Tsukamoto K, Harada K, Shimizu A, Shimada S, Kobayashi T, et al. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF\/KIT protein interactions and the downstream effector, MITF-M. J Pathol 2004; 202: 463\u2013475.","DOI":"10.1002\/path.1538"},{"key":"136652","unstructured":"El-Darouti MA, Marzouk SA, Azzam O, Fawzi MM, Abdel-Halim MR, Zayed AA, et al. Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis). Eur J Dermatol 2006; 16: 17\u201322."},{"key":"136653","doi-asserted-by":"crossref","unstructured":"El Shabrawi-Caelen L, Cerroni L, Medeiros LJ, McCalmont TH. Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype. Am J Surg Pathol 2002; 26: 450\u2013457.","DOI":"10.1097\/00000478-200204000-00006"},{"key":"136654","doi-asserted-by":"crossref","unstructured":"Sigal M, Grossin M, Laroche L, Basset F, Aitken G, Haziza JL, et al. Hypopigmented mycosis fungoides. Clin Exp Dermatol 1987; 12: 453\u2013454.","DOI":"10.1111\/j.1365-2230.1987.tb01948.x"},{"key":"136655","doi-asserted-by":"crossref","unstructured":"Robert C, Moulonguet I, Baudot N, Flageul B, Dubertret L. Hypopigmented mycosis fungoides in a light-skinned woman [2]. Br J Dermatol 1998; 139: 341\u2013343.","DOI":"10.1046\/j.1365-2133.1998.02379.x"},{"key":"136656","doi-asserted-by":"crossref","unstructured":"Amichai B, Grunwald MH, Avinoach I, Halevy S. Hypopigmented mycosis fungoides in a white female. J Dermatol 1996; 23: 425\u2013426.","DOI":"10.1111\/j.1346-8138.1996.tb04046.x"},{"key":"136657","doi-asserted-by":"crossref","unstructured":"Ito A, Sugita K, Ikeda A, Yamamoto O. CD4\/CD8 double-negative mycosis fungoides: a case report and literature review. Yonago Acta Med 2019; 62: 153\u2013158.","DOI":"10.33160\/yam.2019.03.021"},{"key":"136658","doi-asserted-by":"crossref","unstructured":"Kempf W, Kazakov DV, Cipolat C, Kutzner H, Roncador G, Tomasini D. CD4\/CD8 double negative mycosis fungoides with PD-1 (CD279) expression: a disease of follicular helper T-cells? Am J Dermatopathol 2012; 34: 757\u2013761.","DOI":"10.1097\/DAD.0b013e31825b26d1"},{"key":"136659","unstructured":"Poteligeo. Product information. Available on Dec 8, 2025 https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/poteligeo-epar-product-information_en.pdf"},{"key":"136660","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Guarino M, Ortiz P, Gallardo F, Llamas-Velasco M. Clinical and real-world effectiveness of mogamulizumab: a narrative review. Int J Mol Sci 2024; 25: 2203.","DOI":"10.3390\/ijms25042203"},{"key":"136661","doi-asserted-by":"crossref","unstructured":"Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, et al. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncol 2018; 19: 1192\u20131204.","DOI":"10.1016\/S1470-2045(18)30379-6"},{"key":"136662","doi-asserted-by":"crossref","unstructured":"Rao M, Young K, Jackson-Cowan L, Kourosh A, Theodosakis N. Post-inflammatory hypopigmentation: review of the etiology, clinical manifestations, and treatment options. J Clin Med 2023; 12: 1243.","DOI":"10.3390\/jcm12031243"},{"key":"136663","doi-asserted-by":"crossref","unstructured":"Rao AG, Naresh M, Shreeja V, Vsvn S, Sindhuja B, Pranaya B. CD4\/CD8 dual positive pityriasis lichenoides like mycosis fungoides presenting with both pityriasis lichenoid lesions and hypopigmented patches: a rare presentation. Indian J Dermatol 2022; 67: 441\u2013444.","DOI":"10.4103\/ijd.ijd_279_22"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/43932\/52353","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/43932\/52353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:57:54Z","timestamp":1766066274000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/43932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":23,"URL":"https:\/\/doi.org\/10.2340\/actadv.v105.43932","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}